Ghent, Belgium, 07.27.2021 – Cerba Research today announced it was awarded a five‑year contract for Clinical Central Laboratory Services from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH).
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Findings from this research are vital to NIAID’s efforts to advance vaccines, drugs, and diagnostic tools to better diagnose, prevent, and treat infectious diseases. Cerba Research will provide clinical laboratory screening and safety testing for NIAID‑supported clinical trials within the infectious disease area.
“We are pleased to be recognized for our depth and breadth of central and speciality lab solutions across the globe to support NIAID. Through our innovative mindset, courageous people, and our work in vaccines and treatments in the field of infectious diseases, we understand the importance of bringing these to people. Hence, we are committed to supporting the NIAID’s clinical research initiatives to improve health,” said Mario Papillon, chief executive officer, Cerba Research.
About Cerba Research
Cerba Research is a global specialty laboratory and research services organization supporting biopharmaceutical development from discovery through clinical trials. As part of Cerba HealthCare, a leading global player in medical diagnostics with nearly 60 years of expertise in medical biology, Cerba Research delivers high-quality data, scientific insight, and operational excellence across immunology, oncology, infectious diseases, and rare diseases to partners worldwide. For more information, please visit https://www.cerbaresearch.com/
About NIH NIAID:
The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. NIAID is composed of 7 research divisions: the Division of AIDS; the Division of Allergy, Immunology, and Transplantation; the Division of Clinical Research; the Division of Extramural Activities; the Division of Intramural Research; the Division of Microbiology and Infectious Diseases; and the Dale and Betty Bumpers Vaccine Research Center. NIAID scientists conduct intramural research in laboratories located in Bethesda, Rockville, and Frederick, Maryland, and in Hamilton, Montana. More information on NIAID programs, committees, and initiatives can be found on NIAID’s website at www.niaid.nih.gov.